×

White House Government Agencies

  • MONDAY, MAY 21 ATLANTA- Federal Reserve Bank of Atlanta President Raphael Bostic speaks on "Welfare Economics: Trade and a Review of Principles" before the Atlanta Economics Club- 1615 GMT. NEW YORK- Federal Reserve Bank of Philadelphia President Patrick Harker participates in conversation before the Chief Executives Organization's CEO Financial Seminar...

  • MONDAY, MAY 21 ATLANTA- Federal Reserve Bank of Atlanta President Raphael Bostic speaks on "Welfare Economics: Trade and a Review of Principles" before the Atlanta Economics Club- 1615 GMT. NEW YORK- Federal Reserve Bank of Philadelphia President Patrick Harker participates in conversation before the Chief Executives Organization's CEO Financial Seminar...

  • Trump will nominate Robert Wilkie to become permanent VA secretary

    Wilkie led the Department of Veterans Affairs in an acting role after David Shulkin departed in March.

  • WASHINGTON, May 18- The U.S. Federal Communications Commission said on Friday it was referring reports that a website flaw could have allowed the location of mobile phone customers to be tracked to its enforcement bureau to investigate. Senator Ron Wyden, a Democrat, on Friday urged the FCC to investigate, saying on Twitter a "hacker could have used this site to...

  • WASHINGTON, May 18- The U.S. Federal Communications Commission said on Friday it was referring reports that a website flaw could have allowed the location of mobile phone customers to be tracked to its enforcement bureau to investigate. A security researcher said earlier this week that California- based LocationSmart data could have been used to track AT&T...

  • President Donald Trump shakes hands with Veterans Affairs acting Secretary Robert Wilkie after informing him that he will be nominating him to be the new Secretary of the VA, during the Prison Reform Summit at the White House in Washington, U.S., May 18, 2018.

    Wilkie led the Department of Veterans Affairs in an acting role after David Shulkin departed in March.

  • *FDA suggests additional study of contraceptive may be needed. *Company to focus on appealing FDA issues. In an April 16 meeting with the Princeton, New Jersey- based company, the FDA proposed that Agile should reformulate certain properties of Twirla and carry out a new study.

  • May 17- Amgen Inc won U.S. Food and Drug Administration approval on Thursday for the first drug in a new class designed to prevent migraine headaches in adults. The drug, Aimovig, which is given monthly by self-injection, will have a list price of $6,900 a year, or $575 a month, the company said. Some Wall Street analysts had expected a price as high as $10,000 a year.

  • May 17- Amgen Inc won U.S. Food and Drug Administration approval on Thursday for the first drug in a new class designed to prevent migraine headaches in adults. The drug, Aimovig, which is given monthly by self-injection, will have a list price of $6,900 a year, or $575 a month, the company said. Some Wall Street analysts had expected a price as high as $10,000 a month.

  • May 17- Amgen Inc won U.S. Food and Drug Administration approval on Thursday for the first drug to prevent migraine headaches in adults. The drug, Aimovig, which is given monthly by self-injection, will have a list price of $6,900 a year, or $575 a month, the company said. In three separate pivotal trials, patients given Aimovig experienced, on average, between one and...

  • FRIDAY, MAY 18 RICHARDSON, Texas- Federal Reserve Bank of Dallas President Robert Kaplan participates in moderated question-and-answer session before the 12th Annual University of Texas at Dallas Project Management Symposium- 1315 GMT. FRANKFURT- Federal Reserve Bank of Cleveland President Loretta Mester speaks on "Macroprudential and Monetary Policy"...

  • FRIDAY, MAY 18 RICHARDSON, Texas- Federal Reserve Bank of Dallas President Robert Kaplan participates in moderated question-and-answer session before the 12th Annual University of Texas at Dallas Project Management Symposium- 1315 GMT. FRANKFURT- Federal Reserve Bank of Cleveland President Loretta Mester speaks on "Macroprudential and Monetary Policy"...

  • May 17- Amgen Inc won U.S. Food and Drug Administration approval on Thursday for the first drug to prevent migraine headaches in adults. The drug, Aimovig, which is given monthly by self-injection, will have a list price of $6,900 a year, or $575 a month, the company said. Some Wall Street analysts had expected Amgen to price Aimovig as high as $10,000 a year.

  • WASHINGTON, May 17- The U.S. Environmental Protection Agency took steps on Thursday to roll back and delay Obama-era rules aimed at improving safety at chemical plants, which had come in response to a 2013 explosion at a fertilizer plant in Texas that killed 15 people. In January 2017, before Republican President Donald Trump took office, the EPA introduced...

  • WASHINGTON, May 17- The United States is worried about the safety of U.S. citizens held in Venezuela after a riot at a prison there on Wednesday and has appealed again for the release of Mormon missionary Joshua Holt, the State Department said on Thursday. "We continue to have serious concerns about the safety and welfare of U.S. citizens who are being held there," said...

  • But many of the companies immediately pushed back, saying the FDA list of drugmakers may be out of date and that some of the drugs included on it already have generic competitors. The FDA said the list contained all of the inquiries about drugs it had received from generic drugmakers since 2005. The agency said companies on the list may be using FDA safety...

  • NEW YORK— Investors are fearfully watching for signs that inflation is picking up. Stocks tumbled in February when Wall Street thought a big increase was coming, and since then, stocks have rallied when the market received signs that inflation was in check. Even as the Federal Reserve, under Chairman Jerome Powell, raises borrowing costs in the U.S. to stave off...

  • May 17- The U.S. Food and Drug Administration on Thursday listed drugmakers, including Celgene Corp, Mylan NV, Gilead Sciences and Novartis AG, who the regulator says are potentially blocking access to samples of their drugs to delay generic competition. Generic drugmakers may not be able to develop alternatives without access to samples of branded products,...

  • May 17- The U.S. Food and Drug Administration on Thursday named drugmakers including Celgene Corp, Mylan NV, Gilead Sciences and Novartis AG for potentially blocking access to samples of their products to delay generic competition. Generic drugmakers may not be able to develop alternatives without access to samples of branded products, the FDA said.

  • WASHINGTON, May 16- The president and chief executive of Bumble Bee Foods LLC has been indicted by a federal grand jury in California on charges he conspired to fix prices for packaged seafood sold in the United States, the Justice Department said on Wednesday. "Bumble Bee has a strong senior management team in place and will continue to operate our business in...